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Abstract: Our interest in the mechanisms of atherosclerosis progression (ATHp) has led to the recent 
identification of 13 miRNAs and 1285 mRNAs whose expression was altered during ATHp. Here, 
we deepen the functional relationship among these 13 miRNAs and genes associated to oxidative 
stress, a crucial step in the onset and progression of vascular disease. We first compiled a list of 
genes associated to the response to oxidative stress (Oxstress genes) by performing a reverse Gene 
Ontology analysis (rGO, from the GO terms to the genes) with the GO terms GO0006979, 
GO1902882, GO1902883 and GO1902884, which included a total of 417 unique Oxstress genes. Next, 
we identified 108 putative targets of the 13 miRNAs among these unique Oxstress genes, which 
were validated by an integrated miRNA/mRNA counter-expression analysis with the 1285 mRNAs 
that yielded 14 genes, Map2k1, Mapk1, Mapk9, Dapk1, Atp2a2, Gata4, Fos, Egfr, Foxo1, Ccr7, Vkorc1l1, 
Rnf7, Kcnh3, and Mgat3. GO enrichment analysis and a protein–protein-interaction network analysis 
(PPI) identified most of the validated Oxstress transcripts as components of signaling pathways, 
highlighting a role for MAP signaling in ATHp. Lastly, expression of these Oxstress transcripts was 
measured in PBMCs from patients suffering severe coronary artery disease, a serious consequence 
of ATHp. This allowed the identification of FOXO1 and CCR7 as blood markers downregulated in 
CAD. These results are discussed in the context of the interaction of the Oxstress transcripts with 
the ATHp-associated miRNAs. 
Keywords: atherosclerosis progression; counter-expression miRNA/mRNA analysis; oxidative 
stress; FOXO1; CCR7 
 
1. Introduction 
Atherosclerosis (ATH) is a complex, multifactorial disease that affects physiological systems 
from the genomic to the cellular level. Oxidation of low-density lipoproteins (oxLDL)-cholesterol in 
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the intima layer of vascular walls is the driver that provokes an inflammatory response characterized 
by the recruitment of monocytes to arterial walls in response to the secretion of chemokine C-C motif 
ligand 2 (CCL2) by endothelial cells [1].Further interaction of CCL9 and CCL21 with the chemokine 
C-C motif receptor 7 (CCR7) cause the retention of macrophages in inflamed vessel walls that 
contributes to chronic inflammation and plaque progression [2], while the accumulation of 
macrophage-derived foam cells exacerbates inflammatory signaling by producing reactive oxygen 
species (ROS) [3]. Oxidative stress (OS) is caused by the imbalance between the production of ROS 
and antioxidant defenses, and results in the net increase of reactive oxygen and nitrogen species 
(RONS). The vascular wall has a number of oxidant systems (e.g., xanthine oxydases, mitochondrial 
respiratory chain enzymes, NADPH oxidases, etc.) and antioxidant systems, such as superoxide 
dismutase (SOD), thioredoxins, and peroxiredoxins [4], whose expression is regulated by 
transcription factors of the forkhead box, class O (FOXO) family [5] and nuclear factor erythroid 2-
like 2 (NRF2) [6] among others. Furthermore, a link between chronic kidney disease and 
cardiovascular diseases has been proposed that involves oxidative stress through mechanisms such 
as uremic toxin-induced eNOS uncoupling, increased NADPH oxidases activity, or antioxidant 
losses due to dietary restrictions, use of diuretic drugs [7],etc. 
On the other hand, miRNAs are small post-transcriptional regulators involved in the control of 
mRNA function by establishing regulatory networks that can be altered in diseases (see [8] for a 
recent review). These regulatory networks can be very complex, since a single miRNA can interact 
with many different transcripts and these last can display binding sites for multiple miRNAs [9]. The 
identification of miRNAs and downstream mRNA-target interactions is an important topic to study 
regulatory miRNA/mRNA networks and their alterations in human disease. This has been 
approached with computer tools [10], that frequently originate a high number of false positive results 
[11,12], or with experimental techniques, that are complex and cumbersome to perform (see [13] and 
references therein). For these reasons, a number of groups have developed different protocols to 
integrate miRNA target predictions with expression data from microarray experiments in an attempt 
to facilitate the identification of miRNA/mRNA pairs without the difficulties of experimental models 
or the unacceptable high false positive rates of computational methods (see [14] and references 
therein). 
Our group is interested in the role of miRNAs during atherosclerosis progression (ATHp). In a 
previous work, we used the ApoE-/- murine model to profile changes in the expression of miRNAs 
and mRNAs upon systemic treatment with anti-CD40 specific siRNA, and identified 13 upregulated 
miRNAs and 1285 downregulated mRNAs [15,16]. Here, we have used a bioinformatics approach to 
deepen the understanding of miRNA-dependent regulation of gene expression in ATHp, with the 
result of identifying 14 transcripts likely involved in ATHp, and whose expression would be 
regulated by any of the 13 above upregulated miRNAs. These findings have been experimentally 
confirmed by profiling their expression in human samples of PBMCs obtained during coronary artery 
bypass grafting (CABG) in patients who suffered coronary arterial disease, a serious consequence of 
atherosclerosis progression. Whole blood gene expression profiling has the potential to be 
informative about underlying disease mechanisms and offers a genomic signature that allows to 
classify patients with cardiovascular diseases into finer categories [17]. This combined approach of 
bioinformatics and experimental validation has allowed the identification of CCR7 and FOXO1 
transcripts as miRNA-regulated, Oxstress intermediates of coronary arterial disease. 
2. Results 
2.1. Compilation of the List of Genes Associated to the Response to Oxidative Stress (Oxstress Genes) by 
Reverse Gene Ontology Analysis (rGO) 
We first compiled a list of oxstress genes by performing a reverse gene ontology search. GO is a 
widely used tool to convert long lists of genes into meaningful biological information through their 
classification in functional (or structural) groups termed “GO terms” [18,19]. Here, we have made the 
opposite operation, going from the GO terms to the genes, to extract lists of genes associated to GO 
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terms. We first searched the gene ontology database with the primary GO term GO:0006979 (response 
to oxidative stress), which yielded a list of 400 genes that was loaded onto an Excel spreadsheet, and 
then we searched with the child terms GO:1902882, (regulation of response to oxidative stress, which 
yielded 94 genes), GO:1902883, (negative regulation of response to oxidative stress, which yielded 56 
genes), and GO:1902884 (positive regulation of response to oxidative stress, which yielded other 23 
genes). All these genes were loaded onto the same Excel column identified by their GeneSymbol 
unique identifier, and Excel functions were used to delete duplicates entries and to sort unique entries 
so that at the end of the process we had a list of 417 genes of response to oxidative stress that was 
saved for further analysis (Figure 1). 
 
Figure 1. Diagram of the experimental approach used to identify putative miRNA-regulated Oxstress 
genes in atherosclerosis progression. Expression profiling of ATHp (SC24W vs. B8W, step 1, upper 
left box) had previously allowed the detection of 13 upregulated miRNAs, 1285 downregulated 
mRNAs, and 3,658 predicted miRNA targets [15,16]. A reverse GO term analysis of oxidative stress 
genes yielded 417 mRNAs for the primary GO:0006979 (response to oxidative stress) and its child 
terms GO:1902882/3/4 (see text for more details). This list was crossed with the list of 3658 predicted 
miRNA targets (see Materials and Methods) and the 108 entries common to both lists, likely 
representing Oxstress genes targeted by any of the 13 miRNAs, were saved. The list of 108 entries was 
crossed the list of 1,285 downregulated mRNAs to identify those actually downregulated during 
ATHp (step 2, middle left box). Expression of the 14 entries common to both lists (validated Oxstress 
mRNAs) was tested by qPCR to confirm their involvement in ATHp (step 3, lower left box). Steps 1 
and 2 were made in mice or with mice data, step 3 was made with human material. The boxes 
shadowed in colors correspond to the work here performed, while clear boxes correspond to the work 
previously described [15,16]. 
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2.2. Integrated miRNA/mRNA Counter-Expression Analysis Identified Putative miRNA Targets Among 
Oxstress Genes 
We next aimed to identify Oxstress genes that could be targeted by any of the 13 miRNAs 
upregulated in ATHp. We compiled a list of all predicted targets of these upregulated miRNAs by 
using the miRSystem browser (see Materials and Methods) wich yielded 3658 unique predicted 
targets, and used Excel functions to combine this list with the 417 Oxstress genes and to save entries 
common to both lists (108 transcripts). These represented Oxstress transcripts likely regulated by one 
or more of the 13 upregulated miRNAs in ATHp (Figure 1). 
Common knowledge states that true miRNA targets should be counter-regulated with regard to 
their “parental” miRNAs, i.e., targets of upregulated miRNAs should be downregulated in the same 
experimental conditions. Thus, only Oxstress transcripts that were actually downregulated in ATHp 
could be “bona fide” targets of the 13 upregulated miRNAs. To identify these, we combined the list 
of 108 Oxstress transcripts with the 1,285 transcripts previously found to be downregulated by 
microarray hybridization during ATHp (Figure 1) and saved the 14 entries common to both lists. 
These were the following: ATPase Ca2+ transporting cardiac muscle slow twitch 2 (Atp2a2), 
chemokine C-C motif receptor 7 (Ccr7), death associated protein kinase 1 (Dapk1), epidermal growth 
factor receptor (Egfr), FBJ osteosarcoma oncogene (Fos), forkhead box O1 (Foxo1), Gata binding 
protein 4 (Gata4), potassium voltage-gated channel subfamily H (eag-related) member 3 (Kcnh3), 
mitogen-activated protein kinase kinase 1 (Map2k1), mitogen-activated protein kinase 1 (Mapk1), 
mitogen-activated protein kinase 9 (Mapk9), mannoside acetylglucosaminyltransferase 3 (Mgat3), 
ring finger protein 7 (Rnf7), and vitamin K epoxide reductase complex subunit 1 like 1 (Vkorc1l1), 
which were considered as validated Oxstress transcripts likely regulated by one or more of the 13 
upregulated miRNAs in ATHp. Table 1 shows the identity of these 14 transcripts (as Seqnames and 
Refseqs) as well as data on their expression levels (fold change in absolute value) during ATH 
progression extracted from the previous mRNA profiling experiment. Table 1 also shows the output 
of other comparations that will be published elsewhere (see also Supplementary Figure S1 and 
Supplementary Table S1 for the description of the experiments shown in Table 1 and the identification 
of the miRNAs used in each experiment). Finally, we also confirmed the relationship among miRNAs 
and the selected Oxstress transcripts by drawing a graphics of the predicted relationships among 
every Oxstress gene and each one of the 13 miRNAs. Interestingly, while we expected this 
comparison to give an “all against all” drawing, what we got was a kind of “X-shaped” diagram that 
suggested the existence of two main miRNA/mRNA networks of interactions (Figure 2, and Table 2). 
This could be due to the sharing of conserved miRNA binding sites among similar Oxstress 
transcripts, such as the MAPs. A more in deep description of these results will be published 
elsewhere. 
Table 1. Identity and expression of validated Oxstress transcripts. Shown are the Oxstress transcripts 
shown to be putative targets of the miRNAs whose expression was altered during ATHp or after 
treatment with the α-CD40 siRNA (as Fold Change in absolute values). Transcripts are identified by 
their unique GeneSymbol identifier and the specific isoform by its Seqname. Numbers between 
brackets refer to the groups of miRNAs of Supplementary Table S1. No downregulated transcripts 
predicted from upregulated miRNAs in the treatment group were identified. 
Validated Oxstress Transcripts 
Atherosclerosis Progression (SC24W vs. B8W) 
Downregulated Transcripts (Predicted from Upregulated miRNAs [1]) 
Gene Symbol Seq Name Fold Change (abs) p Value 
Atp2a2 NM_001110140 2.50 0011 
Ccr7 NM_007719 13.63 0.019 
Dapk1 NM_029653 3.90 0.002 
Egfr NM_007912 4.43 0.035 
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Fos NM_010234 2.67 0.001 
Foxo1  NM_019739 4.16 0.02 
Gata4 NM_008092 3.63 0.001 
Kcnh3 NM_010601 3.44 0.022 
Map2k1 NM_008927 2.55 0.02 
Mapk1 NM_011949 11.98 0.02 
Mapk9 NM_001163671 2.85 0.005 
Mgat3  NM_010795 27.02 0.005 
Rnf7 NM_011279 33.12 0.02 
Vkorc1l1  NM_001001327 3.95 0.03 
Upregulated Transcripts (Predicted from Downregulated miRNAs [2]) 
Gene Symbol Seq Name Fold Change (abs) p Value  
Pnkd NM_025580 4.88 0.01 
Treatment (α-siCD40/24W vs SC24W) 
Upregulated Transcripts (Predicted from Downregulated miRNAs [3]) 
Gene Symbol Seq Name Fold Change (abs) p Value 
App NM_001198826 2.32 0.03 
Cyth2 NM_011181 2.97 0.0001 
 NM_001112701 2.70 0.01 
Gm3286 NM_001122678 2.15 0.010 
Macrod2 NM_028387 2.41 0.02 
 NM_001013802 2.43 0.03 
Sgk1 NM_001161845 2.94 0.02 
 NM_001161847 2.21 0.02 
Trmt2a NM_001080999 3.16 0.01 
 NM_001195205 4.94 0.01 
Table 2. Predicted miRNAs targeting each one of the 14 validated Oxstress transcripts. For each one 
of the validated Oxstress genes (identified by their gene symbol), shown are the predicted miRNAs 
targeting their 3’UTRs. Analysis was performed at the miRSystem browser (see Materials and 
Methods). In bold, miRNAs predicted to target both Ccr7 and Foxo1. 
MiRNAs Targetting validated Oxstress Transcripts 
Oxstress 
Transcripts 
miRNAs 
Atp2a2 mmu-let7i-5p; mmu-miR-130a-3p; mmu-miR-30a-5p; mmu-miR-465a-5p 
Ccr7 mmu-let7i-5p; mmu-miR-30a-5p; mmu-miR-465a-5p 
Dapk1 mmu-let7i-5p; mmu-miR-122-5p; mmu-miR-125b-5p; mmu-miR-26a-5p;  
mmu-miR-324-5p; mmu-miR-465a-5p; mmu-miR-491-5p; mmu-miR-543-3p 
Egfr mmu-miR-10a-5p; mmu-miR-130a-3p; mmu-miR-27a-3p; mmu-miR-27b-3p 
Fos mmu-miR-543-3p 
Foxo1  mmu-miR-122-5p; mmu-miR-130a-3p; mmu-miR-26a-5p; mmu-miR-27a-3p;  
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mmu-miR-27b-3p; mmu-miR-30a-5p; mmu-miR-465a-5p; mmu-miR-491-5p; 
mmu-miR-543-3p 
Gata4 mmu-miR-122-5p; mmu-miR-125b-5p; mmu-miR-26a-5p; mmu-miR-491-5p; 
Kcnh3 mmu-miR-10a-5p; mmu-miR-125b-5p; mmu-miR-491-5p; 
Map2k1 mmu-miR-130a-3p; mmu-miR-30a-5p; mmu-miR-465a-5p 
Mapk1 mmu-let7i-5p; mmu-miR-122-5p; mmu-miR-130a-3p; mmu-miR-26a-5p;  
mmu-miR-27a-3p; mmu-miR-27b-3p; mmu-miR-30a-5p; mmu-miR-491-5p; 
mmu-miR-543-3p 
Mapk9 mmu-let7i-5p; mmu-miR-10a-5p; mmu-miR-125b-5p; mmu-miR-130a-3p;  
miR-27a-3p; mmu-miR-27b-3p; mmu-miR-543-3p 
Mgat3  mmu-miR-10a-5p; mmu-miR-125b-5p; mmu-miR-27a-3p; mmu-miR-27b-3p; 
mmu-miR-324-5p 
Rnf7 mmu-let7i-5p;mmu-miR-10a-5p;mmu-miR-27a-3p; mmu-miR-27b-3p;  
mmu-miR-543-3p 
Vkorc1l1  mmu-miR-30a-5p; mmu-miR-465a-5p; mmu-miR-491-5p 
 
Figure 2. Predicted functional relationships among the 14 validated Oxstress genes and the 13 
miRNAs upregulated during ATHp. Shown are, on the left the 14 validated Oxstress genes and on 
the right the 13 miRNAs upregulated during ATHp. Lines linking both columns indicate Oxstress 
transcripts that are predicted targets of the corresponding miRNAs. Data obtained from Table 2. 
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2.3. GO Enrichment Analysis and Protein–Protein-Interaction Network Analysis (PPI) Highlight the 14 
Validated Oxstress Transcripts as Components of Signaling Pathways 
On a first glance, the list of 14 validated Oxstress transcripts showed a clear overrepresentation 
of genes linked to mitogen activated protein kinase (MAPK) signaling (Map2k1, Mapk1, Mapk9). To 
confirm this, we performed a GO enrichment analysis on the “GO Molecular Function” category. The 
output of the analysis is shown in Table 3 and in Supplementary Table S2, which show genes included 
in the top 20 functional categories recovered, most of them related to signaling pathways and to 
protein kinase binding and activity, such as transferase activity (Map2k1, Egfr, Mapk9, Dapk1, Rnf7, 
Mapk1, and Mgat3) or MAP kinase kinase activity (Map2k1, Mapk9), but also to DNA-binding 
transcription factor activity (Gata4, Foxo1, Fos), transmembrane transporter activity (Atp2a2, Kcnh3), 
or signaling receptor activity (Egfr, Ccr7). 
Table 3. GO Enrichment analysis for Validated Oxstress mRNAs (n = 14). Shown are the first 20 
Functional Categories at the “GO molecular function” section. Enrichment FDR shows the statistical 
significance (p-value cutoff [False Discovery Rate] = 0.05). Genes in list indicates the number of genes 
of the list that are also included in the “Total genes” of the “Functional Category”. Analysis was 
performed at the “ShinyGOv0.60 Gene Ontology Enrichment Analysis” server (see Materials and 
Methods). 
GO Enrichment analysis for Validated Oxstress mRNAs (n = 14)  
Enrichment 
(FDR) 
Genes in 
List 
Total 
Genes  
Functional Category 
3.9 × 10−5  3  26  
Mitogen-activated protein kinase kinase kinase 
binding  
7.3 × 10−5  3  40  Protein ser/threo/tyrosine kinase activity  
5.6 × 10−4 5  633  Protein kinase activity 
5.6 × 10−4  2  13  MAP kinasekinaseactivity 
5.7 × 10−4 2  16  MAP kinase activity 
5.7 × 10−4 5  693  Transcription factor binding 
5.7 × 10−4 5  735  
Phosphotransferase activity, alcohol group as 
acceptor  
5.7 × 10−4 5  722  Protein kinase binding 
7.7 × 10−4 5  803  Kinase binding 
8.6 × 10−4 5  840  Kinase activity 
1.0 × 10−3  4  456  Protein serine/threonine kinase activity  
1.1 × 10−3  6  1544  ATP binding 
1.1 x10−3 7  2346  Transferase activity 
1.1 × 10−3  5  983  
Transferase activity, transferring phosphorus-
containing groups  
1.1 × 10−3  7  2327  Enzyme binding 
1.1 × 10−3  3  206  Phosphatase binding 
1.1 × 10−3 6  1621  Adenyl nucleotide binding 
1.1 × 10−3  6  1609  Adenyl ribonucleotide binding 
1.1 × 10−3  7  2243  Catalytic activity, acting on a protein  
1.8 × 10−3 6  1798  Drug binding 
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Subsequently, we performed a protein-protein-interaction network analysis (PPI) at the STRING 
database [20,21] (see Materials and Methods). STRING is a database of known and predicted protein-
protein interactions that include direct (physical) and indirect (functional) associations. In the 
STRING output, individual proteins are seen as nodes and their interactions as edges that are color 
encoded according to their nature. Figure 3 shows the PPI analysis of the 14 validated Oxstress genes 
that was composed by 14 nodes (one for each one of the individual Oxstress proteins) and 32 edges 
linking them, a number of edges higher than that expected for random associations that indicated 
that these proteins were at least partially biologically connected. Furthermore, a more detailed 
analysis showed that the graphics followed a three-tier structure centered in the interactions among 
the components of a central cluster (Map2k1, Mapk1, Mapk9, Fos, Egfr, and Foxo1), with their 
surrounding elements (Dapk1, Atp2a2, Gata4), and with satellite elements (Vkorc1l1, Rnf7, Kcnh3, Mgat, 
and Ccr7), a result that highlights a role for MAP signaling in ATHp.  
 
Figure 3. STRING Protein-Protein Interaction network of the 14 validated Oxstress mRNAs. Network 
nodes (colored circles) represent proteins, with a single node representing all the proteins produced 
by a single protein-coding gene, including splicing isoforms alternative polyadenylation forms, etc. 
Colored lines between the nodes (edges) indicate the different types of interaction evidenced by 
fusion of genes (red line), neighborhood of genes (green line), cooccurrence across species (blue line), 
experimental evidence (purple line), text mining of abstracts from literature (yellow line), databases 
(light blue line), co-expression in the same or others species (black line). 
2.4. Experimental Validation Highlights the Downregulation of CCR7 and FOXO1 in PBMCs from Human 
CAD Patients 
Since all the above work was made with data obtained from model mice, we next aimed to 
confirm these results by measuring expression of a selection of the validated Oxstress transcripts by 
qPCR amplification of cDNAs obtained from samples of peripheral blood mononuclear cells 
(PBMCs) extracted from patients with coronary artery disease (CAD, n = 10) and from a control group 
without significant coronary lesions (nonCAD, n = 12, see patient’s demographics in Table 4). For this 
analysis we selected 9 genes, based on the output of the protein-protein-interaction network (Figure 
3): six components of the interaction core (FOS, MAP2K1, MAPK1, EGFR, FOXO1 and MAPK9), one 
surrounding node (GATA4,), two “satellites” (CCR7 and RNF7), and β-ACTIN as internal control for 
normalization. Their expression was tested by duplicate in cDNAs from PBMCs from CAD patients 
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by using TLDA cards, and the results were represented as a volcano plot of expression (as log2[Fold 
Change]) vs. statistical significance (as -log10[p-Value]). Figure 4A shows the result obtained in which 
only two of the Oxstress transcripts (CCR7 and FOXO1) showed a significant downregulation. This 
result was backed by the scatter plot of the individual expression of CCR7 and FOXO1 in CAD and 
nonCAD samples (Figure 4B). RNF7 was also downregulated but its p-Value did not reach statistical 
significance. On the contrary, MAPK9 was upregulated but did not reach statistical significance 
either. The other two genes significantly downregulated in Figure 4A (hnRNP-U and FTO) belong to 
another experiment and will be published elsewhere.  
Lastly, we aimed to identify potential murine miRNAs targeting Foxo1 and Ccr7 to validate their 
human counterparts. We identified two of them (mmu-miR-30a-5p, mmu-miR-465a-5p) that were 
very promising since these targeted both, Foxo1 and Ccr7 (Table 2). Nevertheless, when we profiled 
expression of miR-30a in the human PBMCs, its expression was too low to be detected, and strikingly, 
mmu-miR-465a do not have a human homolog.  
 
 
Figure 4. A) Volcano plot (log2Fold Change vs. -log10(p-Value)) of the expression of the 14 validated 
Oxtress mRNAs in PBMCs of ATH patients. Colored dots identify upregulated genes (represented as 
red dots) or downregulated genes (green dots). The blue line indicates statistical significance. Gene 
Symbols in bold black indicate genes from this study while those in grey belonging to other study 
and will be published elsewhere. B) Scatter Plot of CCR7 and FOXO1 expression in PBMNCs from 
patients with CAD and normal controls without CAD. The mean value and the p value are marked. p 
value was calculated with the nonparametric Mann-Whitney U test. 
3. Discussion 
Our group is interested in the role of miRNAs in ATH progression. We previously tested the 
effect a gene therapy with a siRNA against the immune mediator CD40 (α-siCD40) on the 
development of ATH in which we profiled the expression of miRNAs and mRNAs and compiled a 
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list of 13 upregulated miRNAs and 1285 downregulated mRNAs [15,16]. MicroRNAs (miRNAs) 
constitute a relevant tier of post-transcriptional regulation by their ability to form complex networks 
of miRNA /mRNAs, and disentangling these networks is critical to understand the mechanisms of 
gene expression. Nevertheless, there are severe technical drawbacks that pose limitations in this 
work, with direct experimental isolation of miRNA/mRNA hybrids being a complex and difficult 
task [22,23], while the use of bioinformatic tools rely in complex algorithms generates many false 
positives and produces lists with hundreds of putative targets, challenging further downstream 
processing (see [24,25], and [26] for a recent review). Here, we have presented a combined 
experimental-computational approach to search for miRNA/mRNA pairs related to the response to 
oxidative stress (oxstress) in PBMCs from human patients with coronary artery disease (CAD), a 
complication of atherosclerosis progression, with the ultimate aim of detecting markers of CAD 
progression in blood. To do this, we have integrated data from public databases with our previous 
data on miRNA and mRNA expression in ATHp, and with the data herein generated on the 
expression of a selected group of Oxstress genes in PBMCs from patients with severe coronary artery 
disease (Table 4). 
Table 4. Demographics and Clinical characteristics of patients. Abbreviations: CAD = Coronary artery 
disease, NonCAD = patients without CAD, GFR = Glomerular Filtration Rate, calculated by CKD-EPI 
method, SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure, BP = Blood Pressure, ACE = 
Angiotensin-converting-enzyme, ARB = Angiotensin-Receptor Blockers, CCB = Calcium Channel 
Blocker. Diabetes was considered if patients were taking antidiabetic treatment. p value was 
calculated with the nonparametric Mann-Whitney U test. Standard deviation shown in parenthesis 
for the cholesterol, SBP and DBP values. 
Demographics and Clinical Characteristics of Patients  
 CAD (n = 10) nonCAD (n = 12) p 
Gender (Female/Male) 5/5 5/7 ns 
Age (years) 70 (11) 67 (12) ns 
GFR (ml/min) 25 (13) 64 (30) 0.002 
Diabetes (yes/no) 5/5 3/9 ns 
Cholesterol (mg/dL) 173 (65) 197 (41) ns 
SBP (mmHg) 127 (17) 125 (18) ns 
DBP (mmHg) 7 (11) 73 (14) ns 
DRUGS 
Statins (yes/no) 9/1 7/5 
BP treatment (mean number) 3.1 (0.5) 2.6 (1.3)  
ACE inhibitors (yes) 3 8  
ARB (yes) 3 2  
Β-blockers (yes) 6 5  
CCB (yes) 8 1  
Diuretics (yes) 5 10  
Anti-platelets therapy (yes) 7 1  
We first compiled a list of Oxstress genes by performing a reverse Gene Ontology search in 
which we extracted all genes from the GO term “response to oxidative stress” and its child terms 
(identification step, see Materials and Methods). We next selected those that also appeared in the list 
of 3658 predicted targets of any of the 13 murine miRNAs upregulated in ATHp from our previous 
work with the ApoE-deficient mice [15,16] and shortened this list to those that were actually 
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downregulated during ATHp in the animal model (validation step). To identify these, we combined 
the list of 108 Oxstress transcripts with the 1285 transcripts previously found to be downregulated 
by microarray hybridization during ATHp (Figure 1) and saved the 14 entries common to both lists 
(see Materials and Methods). These were the following: Atp2a2, Ccr7, Dapk1, Egfr, Fos, Foxo1, Gata4, 
Kcnh3, Map2k1, Mapk1, Mapk9, Mgat3, Rnf7, and Vkorc1l1, which were considered as validated 
Oxstress transcripts likely regulated by one or more of the 13 upregulated miRNAs in ATHp. Some 
of these 14 genes have been directly related to ATHp. Thus, Atp2a2 was shown to regulate the NO-
induced contractile phenotype of VSMCs [27] while its activity was repressed by oxidation by 
NADPH oxidases [28], Gata4 activated SMC proliferation by binding to the cyclin D1 promoter [29] 
and regulated positively Nox4 expression [30], inhibition of Egfr reduced T cell infiltration in ATH 
and protected against ATHp[31], fibrosis-related FOS and JUN transcription factors were up-
regulated in foam-cell macrophages [32], while inhibition of Map2k1 was shown to be anti-
atherogenic [33], the knockdown of Mapk1 was shown to suppress the development of coronary 
atherosclerotic heart disease [34], etc.  
Lastly, to confirm the above results, we measured the expression of a selection of the validated 
Oxstress transcripts in samples of PBMCs extracted from patients with coronary artery disease (CAD, 
n = 10) and a control group without significant coronary lesions (nonCAD, n = 12, see patients 
demographics in Table 4). Oxidative stress and the generation of free radicals in the vessel wall are 
crucial in the onset and progression of vascular disease, and the severity of CAD has been associated 
with elevated plasma levels of end products of lipid peroxidation, a marker of oxidative stress and a 
reduced antioxidant capacity [35]. For this analysis we selected nine genes, based on the output of 
the protein–protein-interaction network (Figure 3): four components of the interaction core (FOS, 
MAP2K1, MAPK1, and MAPK9), three surrounding nodes (GATA4, EGFR, and FOXO1), and two 
“satellites” (CCR7 and RNF7) and we could identify that only two of the Oxstress transcripts (CCR7 
and FOXO1) showed a significant downregulation (Figure 2). The identification of CCR7 as 
intermediate of CAD development is not surprising since this chemokine receptor together with its 
ligands CCL19 and CCL21 conforms an axis that has been characterized as a regulator of the 
maturation and migration of T-lymphocytes and lymphoid tumor cells (see [36,37] for reviews), and 
CAD has a deep inflammatory component [38]. CCR7 has been shown to have a positive role in 
plaque regression [2,39], likely by facilitating the emigration of macrophages from plaques [40,41], 
while its genetic depletion was seen to increase T cell accumulation in atherosclerotic lesions and to 
aggravate ATHp[42], results in agreement with our here reported downregulation of CCR7 
expression in CAD patients. Interestingly, CCR7 was shown to protect from the effects of oxidative 
stress [43] while CCR7+ T-cells probed to be sensitive to the effects of H2O2-induced oxidative stress 
[44]. 
Another very interesting finding of this work is the detection of a downregulated FOXO1 
expression in PBMCs of CAD patients. FOXO1 is a member of the forkhead-box O family of 
transcription factors that have key roles in the maintenance of tissue homeostasis (see [45] for a recent 
review), in the cardiac regulation of glucose and lipid metabolic pathways [46], in the development 
of the adaptive immune response by promoting the formation of T-cells and the maturation of B-cells 
and protecting them from oxidative stress [47], in the regulation of adipocyte differentiation [48] etc. 
On the other hand, FOXO1, whose expression is sensitive to reactive oxygen species, has an important 
role in cellular oxidative stress resistance pathways by activating transcription of antioxidant genes 
[5,49]. FOXOs have been also linked to the development of ATHp and CAD by inhibiting 
proliferation and activation of VSMCs and neointimal hyperplasia [50], by mediating protease 
activated receptor 2 (PAR2)-induced proinflammatory gene expression [51], etc. Lastly, CCR7 and 
FOXO1 are functionally linked since CCR7 expression is regulated by FOXO1 [52] and both are 
predicted targets of miR-30a-5p and miR-465a-5p, two of the 13 miRNAs upregulated in ATHp (Table 
2). Nevertheless, when we aimed to measure the expression of miR-30a-5p and miR-465a-5p, we 
found that mmu-miR-465a-5p does not have a human homolog, something not so surprising since, 
in mice, the overexpression of this microRNA has been only associated to aging [53]. On the other 
hand, the lack of detection of miR-30a in human PBMCs could indicate that its expression is tissue-
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restricted. In this sense, it has been reported that expression of miR-30a was increased in aortic 
dissection samples [54], and that downregulation of the miR-30 family contributed to the 
Endoplasmic reticulum stress in the cardiovascular system [55]. Although the functional relationship 
among CCR7, FOXO1, miR-30a, and miR-465a could not be proved, there are other miRNAs that 
could be potential targets of these transcripts (Table 2 and Figure 2), and work is in progress to test 
these associations.  
4. Materials and Methods 
4.1. Reagents 
In this work, we used the following reagents Ficoll (SepMATETM PBMC Isolation Tubes, 
StemCell technologies, Vancouver, British Columbia, Canada), Maxwell RSC miRNA Tissue Kit 
(Cat.# AS1460, Promega, Madison, WI, USA), TaqMan® Advanced miRNA Assays–single tube assays 
(Cat.#A25576, Thermo Fisher, Waltham, MA,USA), TaqMan® Advanced miRNA cDNA Synthesis Kit 
(Cat.# A28007, Thermo Fisher, Waltham, MA, USA). Taqman Gene Expression Assay (Thermo Fisher, 
Walthman, MA, USA) were used to measure expression of hsa-miR30a-5p (Assay ID: 000417) and 
has-miR16-3p (Assay ID:002171). 
4.2. Murine miRNA and mRNA Expression Data 
ATHp experiment in ApoE-deficient mice was approved by the ethic committee for animal 
research of UB-Bellvitge and published elsewhere [16]. Briefly, we used aortic total RNA from ApoE-
deficient mice at basal conditions (8 weeks old), from mice treated with an α-CD40 siRNA (SiCD40) 
for 16 weeks, or from mice treated with a scrambled control siRNA (siSC) also for 16 weeks. MiRNA 
expression was analyzed by using TaqMan Low Density Array cards (TLDAs) and mRNA expression 
was tested by microarray hybridization on a commercial basis[15,16].  
4.3. Patients 
We used stored material from 22 patients undergoing cardiac surgery at Bellvitge University 
Hospital. Among them there were 10 patients with Coronary artery disease (CAD) collected from 
coronary artery bypass grafting (CABG) patients and 12 controls from surgical valvular replacement 
patients without coronary disease (nonCAD). Subjects receiving any antidiabetic medication were 
considered diabetic. The study was authorized by the local ethics committee of Bellvitge University 
Hospital (PR173/18, approved on 5 September 2018) and all patients provided written consent. 
4.4. Human Samples and RNA Extraction 
Blood samples were obtained during the anesthesia induction. PBMC were isolated less than 2 
h after blood collection using ficoll (SepMATETM PBMC Isolation Tubes, StemCell technologies, 
Vancouver, British Columbia, Canada) and frozen in a DMSO-containing solution. We used frozen 
cells for the transcriptomic analysis. Total RNA was extracted from PBMC by using the Maxwell RSC 
miRNA Tissue KIT (Promega, Madison, WI, USA).  
4.5. Expression Profiling of Oxstress Transcripts in Custom-Made TLDA Cards 
cDNA templates were synthesized from PBMC total RNA with the TaqMan® Advanced miRNA 
cDNA Synthesis Kit (Cat# A28007, Thermofisher, Waltham, MA, USA). All real-time quantitative 
PCRs were performed by duplicate in a 384-well format (TaqMan® Low Density Array Cards, 
TLDAs) on a 7900HT Fast Real-Time PCR Instrument (Thermofisher, Waltham, MA, USA) and using 
TaqMan® Fast Advanced Master Mix. The thermal protocol was adjusted for the TaqMan® Fast 
AdvancedMaster Mix. IDs for individual Oxstress transcript assays in the cards were as follows: 
FOXO1 (Hs00231106_m1), MAP2K1 (Hs05512159_s1), MAPK1 (Hs01046830_m1), MAPK9 
(Hs01558224_m1), FOS (Hs04194186_s1), EGFR (Hs01076090_m1), CCR7 (Hs01013469_m1), GATA4 
(Hs00171403_m1), RNF7 (Hs02621493_s1), GAPDH (Hs99999905_m1), and β-ACTIN 
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(Hs01060665_g1). Hsa_miR-30a-5p expression (Assay ID: 000417) were normalized using has-miR-
16-3p (Assay ID:002171) as endogenous reference gene. Expression analysis was performed using the 
comparative CT (ΔΔCT) method with the Expression Suite software v1.1 (Thermofisher, Waltham, 
MA, USA) using β-actin as endogenous control for normalization.  
4.6. Reverse Gene Ontology (rGO) Identification of Genes Involved in the Response to Oxidative Stress 
Oxstress genes were identified by searching the “Gene Ontology” browser 
(http://geneontology.org) [18,19] with the GO terms GO:0006979 (response to oxidative stress), 
GO:1902882 (regulation of response to oxidative stress), GO:1902883 (negative regulation of response 
to oxidative stress) and GO:1902884 (positive regulation of response to oxidative stress). The filter for 
“murine genes” was activated and the link “display genes and gene products annotated to response 
to oxidative stress” was followed. All the entries were copy-pasted onto an Excel spreadsheet, pruned 
of all associated data except the “Genesymbol” unique identifier, sorted and examined to eliminate 
duplicated entries by using the “sorting” and “Data > Remove duplicates” functions of Excel. This 
generated a list of 417 genes linked to Oxstress in Excel format. 
4.7. Detection of Predicted miRNA/mRNA Targets 
The list of 13 miRNAs upregulated during ATH progression in the 24 weeks old mice group 
treated with a scrambled SiRNA for 16 weeks (SC24W) was loaded onto the miRSystem browser 
(http://mirsystem.cgm.ntu.edu.tw),that uses seven different popular algorithms to predict miRNA 
targets [11], and the search was run with the default settings. All the potential target genes were copy-
pasted onto an Excel spreadsheet, duplicated entries were eliminated as above, and the list was 
cleaned of all information but the official “GeneSymbol” and the “gene name”. This generated a list 
of 3658 predicted miRNA unique targets in Excel format (Hueso et al., 2019, In preparation). To 
identify miRNAs targeting the validated Oxstress genes, these were used to interrogate individually 
the miRSystem browser.  
4.8. Counter-expression miRNA/Target mRNA Analysis 
The Excel list of 3658 predicted miRNA unique targets and the list of 417 genes involved in the 
response to oxidative stress were loaded onto the same column of a new Excel sheet. For the counter-
expression analysis, Excel functions were used to alphabetically sort both lists together and to detect 
and extract entries common to both lists which corresponded to Oxstress genes potentially targeted 
(downregulated) by any of the 13 upregulated miRNAs. These were validated by comparing them 
with the list of 1285 mRNAs which were experimentally seen to be downregulated at SC24W vs 
B8W[16]. All these analyses were made by using the “GeneSymbol” as unique identifier for all 
genes/transcripts involved.  
4.9. GO Enrichment Analysis 
The Gene Ontology (GO) analysis [18,19] was performed in the “ShinyGO v0.60: Gene Ontology 
Enrichment Analysis” browser at http://bioinformatics.sdstate.edu/go/ [56]. “Mouse genes”, “p-value 
(FDR) = 0.05” and the “GO Molecular Function” Functional Category were selected for the analysis. 
4.10. STRING Protein-Protein Interaction (PPI) Network Analysis 
PPI network analysis was performed at the STRING database (https://string-db.org) [20,21] after 
loading the list of 14 validated Oxstress mRNAs.  
4.11. Statistics 
The non-parametric Mann–Whitney U-test was used to determine the statistical significance in 
demographics and in the microarray experiment. Data were expressed as mean (DE). A value of p < 
0.05 was considered as statistically significant. Statistical analysis was performed with SPSS 20.0 and 
Int. J. Mol. Sci. 2020, 21, 1943 14 of 17 
 
Volcano Plot was performed with Expression Suite software v1.1 (Thermofisher, Waltham, MA, USA) 
for determining interesting genes using (log) fold changes in conjunction with t-statistics. Transcripts 
levels in the scatterplot were calculated using the delta threshold cycle (ΔCt) method based on the 
relative quantification of CCR7 or FOXO1 normalized to β-ACTIN after determining the first cycle of 
fluorescence detection (ΔCt), and calculating the difference of these threshold cycles. 
5. Conclusions 
In conclusion, here we have deepened the functional relationship among miRNAs and 
transcripts associated to oxidative stress, a crucial step in the onset and progression of vascular 
disease. We have compiled a list of 417 genes associated to the response to oxidative stress (Oxstress 
genes) that after an integrated miRNA/mRNA counter-expression analysis, a protein–protein-
interaction (PPI) network analysis and an expression profiling in PBMCs from patients suffering 
severe coronary artery disease (CAD), a serious consequence of ATHp, allowed the identification of 
FOXO1 and CCR7 as blood markers downregulated in CAD.  
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Abbreviatures 
ACE Angiotensin-converting enzyme 
ARB Angiotensin II Receptor Blockers 
ATHp Atherosclerosis progression 
CABG Coronary Artery Bypass Grafting 
CAD Coronary Artery Disease 
CCB Calcium Channel Blocker  
CKD Chronic Kidney Disease  
DEGs differentiallyexpressed genes 
eNOS endothelial nitric oxide synthase 
miRNAs microRNAs 
NADPH nicotinamide adenine dinucleotide phosphate-oxidases 
OS Oxidative stress 
Oxstress genes genes associated to the response to oxidative stress 
rGO reverse Gene Ontology 
App amyloid beta (A4) precursor protein 
Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 (SERCA) 
Ccr7 chemokine C-C motif receptor 7 
Cyth2 cytohesin2 
Dapk1 death associated protein kinase 1 
Egfr epidermal growth factor receptor 
Fos FBJ osteosarcoma oncogene  
Foxo1 forkhead box O1 
Gata4 Gata binding protein 4 
Gm3286 predicted gene Gm3286 
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Kcnh3 potassium voltage-gated channel subfamily H (eag-related) member 3 
Macrod2 macro domain containing 2 
Map2k1 mitogen-activated protein kinase kinase 1 
Mapk1 mitogen-activated protein kinase 1 
Mapk9 mitogen-activated protein kinase 9 
Mgat3 mannoside acetylglucosaminyltransferase 3  
Rnf7 ring finger protein 7 
Sgk1 serum/glucocorticoid regulated kinase 1  
Trmt2a TRM2 tRNA methyltransferase 2A 
Vkorc1l1 vitamin K epoxide reductase complex subunit 1 like 1 
Pnkd paroxysmal nonkinesiogenic dyskinesia  
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